asthma case presentation

Click here to load reader

Upload: zain-khan

Post on 11-Apr-2017

14 views

Category:

Health & Medicine


0 download

TRANSCRIPT

ASTHMA

Dr Zain Ul AbidinBahawal Victoria [email protected]

Definition

It is a disease characterized by recurrent attacks of breathlessness and wheezing, which vary in severity and frequency from person to person. In an individual, they may occur from hour to hour and day to day.

Wheezing whistling sound produced by resp airways during breathing2

CausesAHR : airway hyper-reactivity is the main cause of asthma

Airway hyper reactivity

Exaggerated response of the airways for a stimulus which triggers little or no response in normal people

4

Other Contributing Factors1.allergan exposure 2.dietary deficiency of antioxidants 3.aspirin (lipoxigenase pathway is intact)4.other drugs(OCP, cholinergic drugs,B blockers)5.exercise (non humidified inhaled air is a trigger)

Pathogenesis3 basic characteristics identified are;A. airway hyper reactivityB. airway inflamationC. airway obstruction

Constricted airways in asthma

Types of asthma1.extrinsic (atopic)2.Intrinsic or adult onset (can be atopic or non atopic)3.exercise induced4.child onset (atopic)5.Occupational6.aspirin induced(lipoxigenase pathway causes bronchoconstriction)7.nocturnal8.pregnancy

Clinical presentationThe patient will be presenting the following symptoms

RECURRENT EPISODES OF Breathlessnes Wheezing Chest tightness Cough (may be the only presentation)

Diurnal patternCharacteristically there is a diurnal pattern.

Symptoms worsen in the early morning

Nocturnal asthmaIf the condition is not properly managed ,there would be nocturnal asthma

Cough and wheezing disturbing sleep

DIAGNOSIS

DiagnosisMostly clinical diagnosis

Symptoms. Recurrent Episodes ofbreathlessnessCoughingWheezingChest tightness

Signs of asthmaSigns

Rapid shallow breathing Pallor or cyanosis due to obstructionHyperexpansion of the chest

Tachycardia for the compensationTachypnea Frequent pausing to catch breath while talking

Investigations Routine pulmonary function testNormal or signs of obstruction

Dispropotionately Decreased FEV /FVC + hyperinflation(inc VC)

and improvement with bronchodilators

FEV is the frced exp vol in 1 second.FVCvol which can be forcibly blown out after full inspiration15

Spirometry

InvestigationsChest X-rayNormal in asymptomatic patientsHyperinflation in symptomatic patients

Hyperinflation of lungs

InvestigationsPeak Flow MeasurementsDiurnal variation in PEF of more than 20% is considered diagnostic

Peak flow m for measuring the resp calibre,and spirometry for the assesment of lung volpeak exp flow is the max speed of expiration 19

InvestigationsSkin Tests

to establish atopy

atopic=allergic type of asthma dua to any allergan20

InvestigationsBlood tests

Eosinophila and increased IgE levels in atopy

21

Management

Management(stepwise approach)Step One.

For patients with mild intermittent asthma_symptoms less than once a week for 3 mnths_less than 2 nocturnal episodesOccasional inhalational use of short acting B adrenoreceptor agonists

Eg salbutamol or terbatuline

ManagementStep Two.introduction of regular preventor therapy..

Inhaled B agonists + Inhaled corticosteroids (eg beclomethasone)

In patients with _exacebration of asthma in last 2 yrs_uses B agonist inhaler 3 times a week or more_reports symptoms three times a week or more_presentation of nocturnal asthma

ManagementStep 3. add on therapy

For patients who are not controlled even by ICS.

Long acting B agonists are added eg salmeterol,formoterol.

Inhaled B agonists + Inhaled corticosteroids + Long acting B agonists

ManagementStep Four. Addition of a 4th drug (if step 3 is not effective)

Nasal corticosteroids are addedInhaled B agonists + Inhaled corticosteroids + Long acting B agonists + nasal corticosteroids

Step Five. Continuous or frequent use of oral Steroids

Prednisolone therapy is prescribed at the lowest amount to control symptoms

ManagementStep Down Therapy

Once asthma control is established,the dose of ICS should be titrated.

Decreasing the dose by 25-50% every 3 months is the reasonable strategy for most patients

Management of acute severe asthmaAcute severe asthmaPEF 33-50%Respiratory rate 25/min or moreHeart rate 110/min or moreInability to complete sentence in 1 breatheManagement1.Oxygen at high concentration (humidified if possible)2.High doses of Inhaled bronchodilators (via nebulizer)3.Systemic corticosteroids4.Intravenous fluids

Oxygen therapy